CVD training and resources

Resources

• Heart UK – The Cholesterol Charity
  • Heart UK has partnered with the NHS Accelerated Access Collaborative (AAC) and the Academic Health Science Network (AHSN) to provide a comprehensive and varied education programme for healthcare professionals.
• CVD data and improvement tool (CVDPREVENT) 
  • The Cardiovascular Disease Prevention Audit (CVDPREVENT) is a national primary care audit of routinely held GP data. The tool provides open access data, with clear actionable insights for those tasked with improving cardiovascular health in England.

Resources for healthcare professionals

• Lipid management pathways: The AHSN Network
  • Lipid management in England drives better CVD outcomes. Two pathways, one for acute cardiovascular disease in secondary care and one for primary care clinicians, have been developed to provide clear guidance for clinicians on how optimal lipid management may be achieved and provide an additional resource to support patient management.
• AAC Pathway
  • A summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease.
• Inclisiran: Medical Directors pack
  • June 2023 – to support medical directors, integrated care boards
    and healthcare professionals with the rapid decision making required to enable the prescribing of inclisiran, a NICE-approved novel therapy – with the wider objective of supporting cholesterol optimisation and reducing cardiovascular deaths.
• Lipid Managment Workforce Competency Framework
  • Following a recent National Lipid Programme Workforce Support Solution, Soar Beyond and the AHSN Network have produced a Lipid Management Competency Framework. The competencies have been developed based on the Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of cardiovascular disease (CVD) within general practice.

Training videos

Introduction to the Eastern AHSN lipid management programme – April 2022.

Dr Max Hickman provides an overview of the Eastern AHSN lipid management programme to support with improving the detection, prevention and treatment of CVD.

Bitesize Lipids event with Ahmet Fuat: Eastern AHSN lipids programme  – March 2023

Dr Ahmet Fuat provides a comprehensive overview to support healthcare professionals to maximise opportunities around lipid management

A guide to lipid management in primary care – October 2022

Dr Max Hickman explains the importance of CVD and lipid management, including new pathways, guidance and novel therapies for healthcare professionals to improve the detection, prevention and treatment of CVD.

East Anglian CV Seminar Series – Lipids and Cardiovascular Risk: Whom, What and How to Treat? – October 2020

This seminar with Dr Paul Flynn, Cambridge University Hospitals NHS Foundation Trust, covered a review of recent guidelines, the criteria and pathway for genetic testing for suspected monogenic familial hypercholesterolaemia (FH), the eligibility criteria and pathway for starting PCSK9 inhibitors and the referral pathways for advice and review in the region’s lipid clinics.

Resources for healthcare professionals

• Implementation pack: regional ICS’s – provides information to support implementation of a population health management approach to blood pressure management across your ICS. For healthcareprofessionals at:

• • Cambridgeshire and Peterborough ICS
  • Hertfordshire and West Essex ICS
  • Norfolk and Waveney ICS
  • Suffolk and North East Essex ICS

• Implementation pack – Primary Care
  • Provides information to support implementation of a population health management approach to blood pressure management within primary care. Intended for Primary Care Networks and practices.​

Training videos

Hypertension in primary care: transforming the prevention of cardiovascular disease – June 2023.

An opportunity to hear from a wide range of speakers including: Dr Matt Kearney, Dr Max Hickman, Dr John Ford and an excellent patient story from Godwin Daudu covering topics related to optimising hypertension management in primary care.

East Anglian CV Seminar Series – Still the biggest killer – September 2021.

Professor Ian Wilkinson provides an indepth overview of hypertension diagnosis and management.

Resources for healthcare professionals

• FH Information Zone
  • Resources for all healthcare professionals to support the early detection and management of patients with Familial Hypercholesterolaemia in the NHS East Genomics region.
• FH Genetic testing pathway
  • The East Genomic Laboratory Hub Familial Hypercholesterolaemia Genetic Testing Pathway provides guidance for healthcare professionals with patients with a high likelihood of FH.

Training videos

East Anglian CV Seminar Series: FH Identification – March 2023

This video is for any healthcare professionals across primary, secondary and tertiary care who look after patients with, or at high risk of developing, atherosclerotic cardiovascular disease to hear from an expert panel including: Dr Javier Gomez, Dr Kate Downes, Dr Paul Flynn and Shelina Rajan.

Mark’s story – October 2022

Hear Mark’s story and experience about being diagnosed and living with FH.

Training videos

East Anglian CV seminar series: HF, whats new? – April 2022

Dr Pegah Salashouri provides an overview of the latest guidelines in management of heart failure.

Training videos

East Anglian CV seminar series – Combination Antithrombotic Therapy: Ensuring Safety and Optimising Efficacy – December 2020

Dr Unni Krishnan a practical overview of the evidence and guidelines that support the use of combination antithrombotic therapy in patients who have a clinical indication for concurrent use of long term anticoagulant therapy as well as antiplatelet therapy for atherosclerotic vascular disease.

Training videos

East Anglian CV seminar series – Trustworthy communication of risk and uncertainty: the Covid experience – April 2021

Professor Sir David Speigelhalter assess the trustworthiness of the way risks and uncertain evidence have been talked about during Covid. In particular, he will look at how background actuarial risk can be used to get a perspective on the risks facing those infected by the virus, and how the potential benefits and harms of vaccines can be communicated.